Overexpression of ERG and Wild-Type PTEN Are Associated with Favorable Clinical Prognosis and Low Biochemical Recurrence in Prostate Cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of ERG and Wild-Type PTEN Are Associated with Favorable Clinical Prognosis and Low Biochemical Recurrence in Prostate Cancer
Authors
Keywords
Negative staining, Radical prostatectomy, Cell staining, Immunohistochemistry techniques, Nuclear staining, Immunostaining, Surgical pathology, Prognosis
Journal
PLoS One
Volume 10, Issue 4, Pages e0122498
Publisher
Public Library of Science (PLoS)
Online
2015-04-22
DOI
10.1371/journal.pone.0122498
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer
- (2015) Kyung Park et al. NEOPLASIA
- Cysteine- rich secretory protein 3 (CRISP3), ERG and PTEN define a molecular subtype of prostate cancer with implication to patients’ prognosis
- (2014) Samir Al Bashir et al. Journal of Hematology & Oncology
- Reduced CD147 expression is linked to ERG fusion-positive prostate cancers but lacks substantial impact on PSA recurrence in patients treated by radical prostatectomy
- (2013) Katharina Grupp et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- ERG Overexpression and PTEN Status Predict Capsular Penetration in Prostate Carcinoma
- (2013) Raymond B. Nagle et al. PROSTATE
- Prognostic value of ERG oncoprotein in prostate cancer recurrence and cause-specific mortality
- (2013) E. Sophie Spencer et al. PROSTATE
- ERG expression and prostatic adenocarcinoma
- (2013) Montse Verdu et al. VIRCHOWS ARCHIV
- Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
- (2012) Antje Krohn et al. AMERICAN JOURNAL OF PATHOLOGY
- Antibody-Based Detection ofERGRearrangements in Prostate Core Biopsies, Including Diagnostically Challenging Cases: ERG Staining in Prostate Core Biopsies
- (2012) Scott A. Tomlins et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- An immunohistochemical signature comprising PTEN, MYC, and Ki67 predicts progression in prostate cancer patients receiving adjuvant docetaxel after prostatectomy
- (2012) Emmanuel S. Antonarakis et al. CANCER
- ERG protein expression reflects hormonal treatment response and is associated with Gleason score and prostate cancer specific mortality
- (2012) Tarek A. Bismar et al. EUROPEAN JOURNAL OF CANCER
- ERG Immunohistochemistry and Clinicopathologic Characteristics in Korean Prostate Adenocarcinoma Patients
- (2012) Ja Hee Suh et al. Korean Journal of Pathology
- Novel, gross chromosomal alterations involving PTEN cooperate with allelic loss in prostate cancer
- (2012) Alison H M Reid et al. MODERN PATHOLOGY
- Expression of ERG oncoprotein is associated with a less aggressive tumor phenotype in Japanese prostate cancer patients
- (2012) Takahiro Kimura et al. PATHOLOGY INTERNATIONAL
- Immunohistochemistry for ERG Expression as a Surrogate for TMPRSS2-ERG Fusion Detection in Prostatic Adenocarcinomas
- (2011) Alcides Chaux et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy
- (2011) Sarah Minner et al. CLINICAL CANCER RESEARCH
- Common Gene Rearrangements in Prostate Cancer
- (2011) Mark A. Rubin et al. JOURNAL OF CLINICAL ONCOLOGY
- ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer
- (2011) A Marije Hoogland et al. MODERN PATHOLOGY
- Antibody EPR3864 is specific for ERG genomic fusions in prostate cancer: implications for pathological practice
- (2011) Geert JLH van Leenders et al. MODERN PATHOLOGY
- Immunohistochemical ETS-related gene detection in a Japanese prostate cancer cohort: Diagnostic use in Japanese prostate cancer patients
- (2011) Bungo Furusato et al. PATHOLOGY INTERNATIONAL
- Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis
- (2010) X. Mao et al. CANCER RESEARCH
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Single Focus Prostate Cancer: Pathological Features and ERG Fusion Status
- (2010) Sara M. Falzarano et al. JOURNAL OF UROLOGY
- TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of caucasian, african-american and japanese patients
- (2010) Cristina Magi-Galluzzi et al. PROSTATE
- Prevalence of TMPRSS2-ERG Fusion Prostate Cancer among Men Undergoing Prostate Biopsy in the United States
- (2009) J.-M. Mosquera et al. CLINICAL CANCER RESEARCH
- Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression
- (2009) Bo Han et al. MODERN PATHOLOGY
- ETS rearrangements and prostate cancer initiation
- (2009) Brett S. Carver et al. NATURE
- Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
- (2009) Brett S Carver et al. NATURE GENETICS
- TMPRSS2:ERG Fusion Identifies a Subgroup of Prostate Cancers with a Favorable Prognosis
- (2008) O. R. Saramaki et al. CLINICAL CANCER RESEARCH
- Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
- (2008) Maisa Yoshimoto et al. MODERN PATHOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search